The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis

This publication has 20 references indexed in Scilit:

• STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling
  Journal of Hematology & Oncology, 2018
• The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1
  Molecular Cancer, 2018
• The RARS–MAD1L1 Fusion Gene Induces Cancer Stem Cell–like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma
  Clinical Cancer Research, 2018
• RNPC1 inhibits non-small cell lung cancer progression via regulating miR-181a/CASC2 axis
  Biotechnology Letters, 2017
• A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
  Journal of Hematology & Oncology, 2017
• LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells
  Oncotarget, 2016
• ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma
  Oncotarget, 2016
• MACC1 – a novel target for solid cancers
  Expert Opinion on Therapeutic Targets, 2013
• The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
  Cell, 2011
• MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
  Nature Medicine, 2008